Sab Biotherapeutics Inc. (SABS)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
2. 53
-0.06
-2.3166%
$
271.14M Market Cap
0.1 P/E Ratio
- Div Yield
756,767 Volume
0 Eps
$ 2.59
Previous Close 
Want to track SABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sab Biotherapeutics Inc. (SABS) Statistics
Valuation metrics
Market Cap 271.14M
Enterprise value 268M
Trailing P/E (ttm) 0.83
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 1.11
Enterprise Value/Revenue -
Enterprise Value/EBITDA -28.43
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 542.55K
Average volume (90 days) 582.12K
Price summary
52-Week low 2.1
52-Week high 5.15
Beta -
50-Day moving average 3.25
200-Day moving average 3.69
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 5 Jan 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.05%
Return on equity -0.07%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.29
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 9.22%
Book value per share (mrq) 2.69
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
